We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
1426
PUT
Viatris
VTRS
$20.4B
$7.91M 0.01%
400,000
+355,000
+789% +$6.96M
PG icon
1427
PUT
Procter & Gamble
PG
$336B
$7.9M 0.01%
63,500
-112,300
-64% -$13.3M
NVO
1428
Novo Nordisk
NVO
$208B
$7.89M 0.01%
305,210
+94,956
+45% +$2.4M
ISRG icon
1429
CALL
Intuitive Surgical
ISRG
$127B
$7.88M 0.01%
43,800
+600
+1% +$104K
GDV icon
1430
Gabelli Dividend & Income Trust
GDV
$2.6B
$7.87M 0.01%
+366,000
New +$7.82M
SHG icon
1431
Shinhan Financial Group
SHG
$32.8B
$7.87M 0.01%
224,857
-191,580
-46% -$6.8M
SPGI icon
1432
CALL
S&P Global
SPGI
$121B
$7.86M 0.01%
32,100
+6,100
+23% +$1.52M
JBSS icon
1433
John B. Sanfilippo & Son
JBSS
$967M
$7.83M 0.01%
81,070
-28,948
-26% -$2.52M
PTR
1434
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
$7.82M 0.01%
153,884
+15,598
+11% +$810K
ZM icon
1435
PUT
Zoom
ZM
$28.2B
$7.81M 0.01%
+102,500
New +$9.23M
BIP icon
1436
Brookfield Infrastructure Partners
BIP
$19.2B
$7.81M 0.01%
264,492
+192,213
+266% +$5.21M
CHRS icon
1437
Coherus Oncology
CHRS
$217M
$7.8M 0.01%
384,857
+246,898
+179% +$4.93M
HYD icon
1438
VanEck High Yield Muni ETF
HYD
$4.43B
$7.78M 0.01%
120,763
+78,120
+183% +$5.01M
PRFT
1439
DELISTED
Perficient Inc
PRFT
$7.76M 0.01%
201,265
-803
-0.4% -$29.1K
ENTG icon
1440
Entegris
ENTG
$18.1B
$7.76M 0.01%
164,932
-134,509
-45% -$5.67M
TYL icon
1441
Tyler Technologies
TYL
$12.7B
$7.76M 0.01%
29,550
-343
-1% -$84K
MAT icon
1442
Mattel
MAT
$4.38B
$7.75M 0.01%
680,824
-187,583
-22% -$2.15M
CBM
1443
DELISTED
Cambrex Corporation
CBM
$7.75M 0.01%
130,265
+100,492
+338% +$5.38M
INDA icon
1444
iShares MSCI India ETF
INDA
$6.89B
$7.7M 0.01%
229,325
-31,798
-12% -$1.05M
GGAL icon
1445
Galicia Financial Group
GGAL
$7.99B
$7.68M 0.01%
591,063
+392,785
+198% +$9.24M
SBGI icon
1446
Sinclair Inc
SBGI
$992M
$7.68M 0.01%
179,740
+121,044
+206% +$5.86M
IWB icon
1447
iShares Russell 1000 ETF
IWB
$48.2B
$7.66M 0.01%
46,554
+40,435
+661% +$6.64M
USFD icon
1448
US Foods
USFD
$22.2B
$7.6M 0.01%
184,958
+53,329
+41% +$2.06M
AA icon
1449
Alcoa
AA
$11.9B
$7.59M 0.01%
378,386
+37,575
+11% +$781K
SPHQ icon
1450
Invesco S&P 500 Quality ETF
SPHQ
$19.4B
$7.57M 0.01%
225,829
+215,547
+2,096% +$7.19M

Similar funds

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.